Market Overview:
The global epoprostenol sodium market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of pulmonary arterial hypertension (PAH) and rising demand for better treatment options. The market is segmented on the basis of type, application, and region. On the basis of type, it is divided into purity above 98%, purity below 98%, and others. In terms of application, it is classified into injection and other applications. Geographically, it is analyzed across North America, Latin America, Europe Asia Pacific (APAC), and Middle East & Africa (MEA). Some key players operating in this market are Actelion Pharmaceuticals Ltd., Bayer AG., Boehringer Ingelheim GmbH., GlaxoSmithKline plc., Novartis AG., Pfizer Inc., Sanofi S.
Product Definition:
Epoprostenol Sodium is a prostaglandin which is used to relieve the symptoms of pulmonary arterial hypertension. It relaxes the muscles in the walls of the blood vessels, improving blood flow. This helps to reduce shortness of breath and improve exercise capacity.
Purity Above 98%:
Epoprostenol sodium is a pure form of the drug used to treat pulmonary hypertension in children. It works by opening airways and reducing the workload on the heart. The U.
Purity Below 98%:
Epoprostenol sodium is a pure form of the drug used to treat pulmonary hypertension in neonates. It is also used as an anti-ischemic agent in patients suffering from cerebral palsy, traumatic brain injury or stroke. The product has been approved by the U.
Application Insights:
The epoprostenol sodium injection was the dominant application segment in 2017. The drug is used for the treatment of cardiovascular diseases, such as heart failure and angina pectoris. It is also employed for pain management after surgery as well as to reduce swelling after injury. In addition, it helps in reducing pressure on the brain caused due to increased intracranial pressure and assists in treating brain aneurysm without any surgical intervention.
Other applications of epoprostenol include its employment for treating various other disorders including diabetes mellitus type 2; acute respiratory distress syndrome (ARDS); diabetic foot ulcers; Crohn¢â‚¬â„¢s disease; rheumatoid arthritis; osteoarthritis; gouty arthritis and fibrous dysplasia among others.
Regional Analysis:
North America dominated the global epoprostenol sodium market in 2017. The region is expected to witness a CAGR of XX% over the forecast period owing to increasing cases of heart failure and other cardiovascular diseases, growing geriatric population, rising awareness about advanced medicines and presence of well-established healthcare facilities. In addition, supportive government initiatives for R&D investments are also anticipated to drive growth in this region. For instance, according to FDA website “The Orphan Drug Act (ODA)†was passed in 1983 with an aim to encourage development of drugs for treatment that affect fewer than 20000 people in U.S.
In Asia Pacific, epoprostenol sodium market is expected witness significant growth during the forecast period due its increasing demand from Japan.
Growth Factors:
- Increasing prevalence of pulmonary hypertension
- Rising geriatric population
- Growing demand for innovative and advanced therapies for the treatment of pulmonary hypertension
- Technological advancements in the field of epoprostenol sodium therapy
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Epoprostenol Sodium Market Research Report
By Type
Purity Above 98%, Purity Below 98%,
By Application
Injection, Other,
By Companies
Sun Pharmaceutical, Pfizer CentreOne, Sanofi, Ausun Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Epoprostenol Sodium Market Report Segments:
The global Epoprostenol Sodium market is segmented on the basis of:
Types
Purity Above 98%, Purity Below 98%,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Injection, Other,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sun Pharmaceutical
- Pfizer CentreOne
- Sanofi
- Ausun Pharmaceutical
Highlights of The Epoprostenol Sodium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity Above 98%
- Purity Below 98%
- By Application:
- Injection
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epoprostenol Sodium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epoprostenol sodium is a medication used to treat a variety of heart conditions. It works by relaxing the muscles in the heart, which can help improve blood flow and reduce symptoms. Epoprostenol sodium is also used to prevent or reduce chest pain after surgery.
Some of the major players in the epoprostenol sodium market are Sun Pharmaceutical, Pfizer CentreOne, Sanofi, Ausun Pharmaceutical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Epoprostenol Sodium Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Epoprostenol Sodium Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Epoprostenol Sodium Market - Supply Chain
4.5. Global Epoprostenol Sodium Market Forecast
4.5.1. Epoprostenol Sodium Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Epoprostenol Sodium Market Size (000 Units) and Y-o-Y Growth
4.5.3. Epoprostenol Sodium Market Absolute $ Opportunity
5. Global Epoprostenol Sodium Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Epoprostenol Sodium Market Size and Volume Forecast by Type
5.3.1. Purity Above 98%
5.3.2. Purity Below 98%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Epoprostenol Sodium Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Epoprostenol Sodium Market Size and Volume Forecast by Application
6.3.1. Injection
6.3.2. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Epoprostenol Sodium Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Epoprostenol Sodium Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Epoprostenol Sodium Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Epoprostenol Sodium Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Epoprostenol Sodium Demand Share Forecast, 2019-2026
9. North America Epoprostenol Sodium Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Epoprostenol Sodium Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Epoprostenol Sodium Market Size and Volume Forecast by Application
9.4.1. Injection
9.4.2. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Epoprostenol Sodium Market Size and Volume Forecast by Type
9.7.1. Purity Above 98%
9.7.2. Purity Below 98%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Epoprostenol Sodium Demand Share Forecast, 2019-2026
10. Latin America Epoprostenol Sodium Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Epoprostenol Sodium Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Epoprostenol Sodium Market Size and Volume Forecast by Application
10.4.1. Injection
10.4.2. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Epoprostenol Sodium Market Size and Volume Forecast by Type
10.7.1. Purity Above 98%
10.7.2. Purity Below 98%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Epoprostenol Sodium Demand Share Forecast, 2019-2026
11. Europe Epoprostenol Sodium Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Epoprostenol Sodium Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Epoprostenol Sodium Market Size and Volume Forecast by Application
11.4.1. Injection
11.4.2. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Epoprostenol Sodium Market Size and Volume Forecast by Type
11.7.1. Purity Above 98%
11.7.2. Purity Below 98%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Epoprostenol Sodium Demand Share, 2019-2026
12. Asia Pacific Epoprostenol Sodium Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Epoprostenol Sodium Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Epoprostenol Sodium Market Size and Volume Forecast by Application
12.4.1. Injection
12.4.2. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Epoprostenol Sodium Market Size and Volume Forecast by Type
12.7.1. Purity Above 98%
12.7.2. Purity Below 98%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Epoprostenol Sodium Demand Share, 2019-2026
13. Middle East & Africa Epoprostenol Sodium Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Epoprostenol Sodium Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Epoprostenol Sodium Market Size and Volume Forecast by Application
13.4.1. Injection
13.4.2. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Epoprostenol Sodium Market Size and Volume Forecast by Type
13.7.1. Purity Above 98%
13.7.2. Purity Below 98%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Epoprostenol Sodium Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Epoprostenol Sodium Market: Market Share Analysis
14.2. Epoprostenol Sodium Distributors and Customers
14.3. Epoprostenol Sodium Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sun Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer CentreOne
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ausun Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
